Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.

Kanishk LuhachGiriraj T KulkarniVijay P SinghBhupesh Sharma

Published in: The Journal of pharmacy and pharmacology (2022)

Cilostazol rectified core behavioural traits while producing significant changes to biochemistry in the brain, suggesting benefits of cilostazol administration in experimental models of ASD.

Keyphrases

autism spectrum disorder
attention deficit hyperactivity disorder
intellectual disability
pregnant women
traumatic brain injury
white matter
genome wide
gene expression
dna methylation
cerebral ischemia